Showing results (1-10 of 119) with videos related to
Sort By:
Pageof 12
Current Opinion in Chemical Biology|June 21, 2011
High-content screening in infectious diseasesPriscille Brodin, Thierry ChristopheMedecine Sciences : M/S|March 7, 2015
[High content screening in chemical biology: overview and main challenges]Priscille Brodin, Elaine DelNery, Emmanuelle SoleilhacMethods in Molecular Biology (Clifton, N.J.)|March 18, 2015
Testing chemical and genetic Modulators in Mycobacterium tuberculosis infected cells using phenotypic assaysVincent Delorme, Ok-Ryul Song, Alain Baulard, et al.Methods in Molecular Biology (Clifton, N.J.)|January 30, 2019
Mitochondrial Dynamics and Activity in Legionella-Infected CellsOk-Ryul Song, Priscille Brodin, Carmen Buchrieser, et al.Current Opinion in Microbiology|November 28, 2017
Host-pathogen systems for early drug discovery against tuberculosisValentin Trofimov, Joana Costa-Gouveia, Eik Hoffmann, et al.Frontiers in Immunology|February 15, 2018
Proteomics of <i>Mycobacterium</i> Infection: Moving towards a Better Understanding of Pathogen-Driven ImmunomodulationEik Hoffmann, Arnaud Machelart, Ok-Ryul Song, et al.Drug Discovery Today|May 24, 2017
Host-directed therapies offer novel opportunities for the fight against tuberculosisArnaud Machelart, Ok-Ryul Song, Eik Hoffmann, et al.Infection and Immunity|November 26, 2003
CD8+-T-cell responses of Mycobacterium-infected mice to a newly identified major histocompatibility complex class I-restricted epitope shared by proteins of the ESAT-6 familyLaleh Majlessi, Marie-Jésus Rojas, Priscille Brodin, et al.Frontiers in Immunology|October 19, 2020
Paradoxical Roles of the MAL/Tirap Adaptor in PathologiesImène Belhaouane, Eik Hoffmann, Mathias Chamaillard, et al.Drug Discovery Today|February 1, 2017
How can nanoparticles contribute to antituberculosis therapy?Joana Costa-Gouveia, José A Aínsa, Priscille Brodin, et al.Pageof 12